SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000905718-21-000411
Filing Date
2021-03-15
Accepted
2021-03-15 07:57:28
Documents
2
Group Members
COMMODORE CAPITAL MASTER LP

Document Format Files

Seq Description Document Type Size
1 INITIAL FILING satsumapharm_13gmar32021.htm SC 13G 49816
2 JOINT FILING AGREEMENT ex-1jointfilingagreement.htm EX-1 4153
  Complete submission text file 0000905718-21-000411.txt   55554
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Subject) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91126 | Film No.: 21739860
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVE 12TH FLOOR NEW YORK NY 10153 917-970-1730
COMMODORE CAPITAL LP (Filed by) CIK: 0001831942 (see all company filings)

IRS No.: 832659606 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G